HOOSIER HEALTHWISE SCOPE OF WORK. The Contractor shall utilize a Pharmacy and Therapeutics Committee which shall meet regularly to make recommendations for changes to the PDL and/or formulary. In accordance with IC 00-00-00-00, prior to removing one (1) or more drugs from the PDL and/or formulary or otherwise placing new PA criteria on one (1) or more drugs, the Contractor shall submit the proposed change to the OMPP which shall forward the proposal to the DUR Board. Such changes shall be submitted at least thirty-five (35) calendar days in advance of the proposed change. The Contractor shall also meet with OMPP staff, as directed by OMPP, to answer questions about the clinical rationale for the proposed change. The DUR Board will provide a recommendation regarding approval of the proposed change to the PDL and/or formulary in accordance with the terms of IC 12-15-35-
Appears in 4 contracts
Samples: Amendment to Contract, Contract Amendment, Contract
